Zeke Capital Advisors, LLC Vallon Pharmaceuticals, Inc. Transaction History

Zeke Capital Advisors, LLC

  • $1.53 Billion
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$0.42 - $2.27 $6,300 - $34,050
-15,000 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$4.02 - $7.3 $20,099 - $36,500
-5,000 Reduced 25.0%
15,000 $90,000
Q3 2021

Nov 15, 2021
SELL
$3.85 - $9.68 $38,500 - $96,800
-10,000 Reduced 33.33%
20,000 $145,000
Q2 2021

Aug 16, 2021
BUY
$3.66 - $5.83 $109,800 - $174,900
30,000 New
30,000 $163,000

About Vallon Pharmaceuticals, Inc.

VLON Quotes by TradingView
  • Ticker VLON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,512,800
  • Description
  • Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the ...
More about VLON
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email